Experian calms investors's nerves - Guardian Unlimited
Guardian Unlimited, UK - Jan 30, 2008
Elsewhere pharmaceuticals group Shire fell 36p to 899p on concerns about potential sales of its Vyvanse ADHD treatment. Please note: In order to post a …
Find Out More:
- Dyslexics need concessions, universities told - Guardian Unlimited
- How to avoid fat fresher syndrome - Guardian Unlimited
- EMI needs love: does it need Hands? - Guardian Unlimited
- Spelling out the needs of dyslexic children - Guardian Unlimited
- Many children with learning difficulties are not getting the help … - Guardian Unlimited
Books:
- Born on a Blue Day: Inside the Extraordinary Mind of an Autistic Savant
- You And Your A.d.d. Child How To Understand And Help Kids With Attention Deficit Disorder
- ADHD Treatment
- Siblings of Children With Autism: A Guide for Familes (Topics in Autism)
- Ritalin Is Not The Answer: A Drug-Free, Practical Program for Children Diagnosed with ADD or ADHD
February 1st, 2008
Vyvanse
Leave a Reply